Phase II study of capecitabine as palliative treatment for patients with recurrent and metastatic squamous head and neck cancer after previous platinum-based treatment

por Martinez-Trufero, J, Isla, D, Adansa, J C, Irigoyen, A, Hitt, R, Gil-Arnaiz, I, Lambea, J, Lecumberri, M J, Cruz, J J
Publicado 2010

Oral anticoagulation with vitamin K inhibitors and determinants of successful self-management in primary care

por Tamayo Aguirre, E., Galo-Anza, A., Dorronsoro-Barandiaran, O., del Burgo, E. Uranga-Saez, Ostiza Irigoyen, A., Garcia-Carro, A., Lopez-Fernandez, I., Colera, N., Saez-Garbayo, P., Tamayo-Uria, I.
Publicado 2016

Incidence and prognostic impact of U2AF1 mutations and other gene alterations in myelodysplastic neoplasms with isolated 20q deletion

por Castillo, Martín I., Ribate, Villamón E., Muñoz, Calabuig M., Santillana, Sanz G., Taboada, Such E., Casterá, Mora E., Abinzano, Calasanz M. J., Barranco, Irigoyen A., Nieto, Collado R., Pampliega, Vara M., Blanco, M. L., de Andrés, Álvarez S., de Oteyza, Pérez J., del Castillo, Bernal T., Font, Granada I., Cayuela, Jerez A., Díez‐Campelo, M., Sánchez, Abellán R., Vercet, Solano C., Díaz, Tormo M.
Publicado 2023